Business NewsPR NewsWire • OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

SAN DIEGO, March 15, 2011 /PRNewswire/ -- OncoSec Medical Inc. (OTC Bulletin Board: ONCSD), a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. (NYSE Amex

View More : http://www.prnewswire.com/news-releases/oncosec-medical-licenses-non-dna-vaccine-tumor-therapy-technology-from-inovio-ph...
Releted News by prnewswire
OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
New Report: Largest Portion of Job Openings Projected for New York by 2018 in 'Middle-Skill' Sector
Video and Stills From Kia Motors Corporation Available on thenewsmarket.com: Top Honors for Kia Motors at Red Dot Design Awards